Rx Savings' Rea on Mylan Under Scrutiny for EpiPen Price(Audio)

Bloomberg Intelligence

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Michael Rea, CEO of Rx Savings Solutions, to discuss Mylan's EpiPen price hike, currently under scrutiny.

See omnystudio.com/listener for privacy information.

2016-08-24 8 min Transcript

Available Results

Generated results are saved to your library for reuse and search.

No generated results are available for this episode yet.

Transcript

Open the Transcript tab to load the transcript.

Chapters

No chapters available.